Tag: Home Infusion Therapy
Float follows ‘North Star’ to growth
May 22, 2024Theresa Flaherty, Managing Editor
SAN FRANCISCO – With its latest round of funding, Float, a provider of on-demand home infusion staffing and technology, is poised to expand its “frictionless” solutions, says CEO Ryan Johnson.
The $10 million in Series A funding, announced in April, has allowed the company to quickly scale its solutions and expand into Arizona.
“Each month, we’re staffing over 1,800 visits and this month we were up 15% month on month, so we continue to grow quite quickly,”...
InfuSystem to repurchase up to $20 million in stock
May 22, 2024HME News Staff
ROCHESTER HILLS, Mich. – InfuSystem Holdings has announced a stock repurchase program authorizing the company to repurchase up to $20 million of its outstanding common stock through June 30, 2026. The program supersedes the previous authorization, which was set to expire June 30, 2024. Under the previous authorization, InfuSystem repurchased approximately 550,000 shares of stock for approximately $6.2 million. “This authorization will continue the company’s long-standing buyback...
Float hits $15M in funding
April 15, 2024HME News Staff
SAN FRANCISCO – Float, a provider of on-demand home infusion nurses, has announced $10 million in Series A funding led by Canvas Ventures, whose General Partner Mike Ghaffary has joined Float's board, with participation from Wave Capital, Y Combinator, Burst Capital, and Also Capital. With $15 million in total funding, Float now has the capital, talent, and technology to continue tackling a root cause of health care's most pressing issues: chronic illness. "After years in the emergency...
Part B infusion visits decrease
March 20, 2024HME News Staff
WASHINGTON – Home infusion service visits continued to decline in the first half of 2023, according to CMS’s annual monitoring report on the Medicare Part B home infusion therapy (HIT) benefit. The HIT market is concentrated, with seven of the 82 HIT suppliers providing about 56% of the HIT service visits in the past 12 months. The quarterly number of HIT supplier organizations increased from 42 in Q1 2021 to a quarterly high of 74 in Q3 2022 before dropping to 60 in Q2 2023, according...
NHIA makes payer recommendations
March 13, 2024HME News Staff
ALEXANDRIA, Va. – The National Home Infusion Association (NHIA) has developed recommendations for commercial, Medicaid and Medicare Advantage payers to improve patient outcomes and experience, reduce administrative burden, and improve timely access to home infusion services.
The 2024 recommendations, designed to be incorporated into contracts between health plans and home and alternate site infusion providers, address value-based programs, secondary payers, prior authorization,...
Option Care monitors ‘vigorous’ competition
March 1, 2024Theresa Flaherty, Managing Editor
BANNOCKBURN, Ill. – The trend of payers integrating with providers, including Elevance Health’s recent acquisition of Paragon Healthcare, a Texas-based infusion provider, is a shift that Option Care Health is keeping a close eye on, says CEO John Rademacher.
“They're vigorous competitors and so we take that full view as we're approaching the marketplace,” he said on a recent call to discuss the company’s fourth quarter and full year earnings. “Our...
NHIA ramps up networking, highlights women in leadership
January 19, 2024Theresa Flaherty, Managing Editor
AUSTIN, Texas – Networking will remain front and center at the National Home Infusion Association’s 2024 Annual Conference, says COO Jennifer Charron.
This year’s event will once again feature its popular roundtable sessions, but they have been moved to the beginning of the conference to allow attendees to meet each other early on, she says.
“(Attendees) felt the roundtables really helped develop long-term relationships outside of the conference,” she...
Elevance Health ramps up integrated approach to infusion
January 12, 2024Theresa Flaherty, Managing Editor
INDIANAPOLIS – The acquisition of Paragon Healthcare by Elevance Health, formerly Anthem, “builds out” the health insurer’s infusion platform and better positions it to compete in a vertically integrating market, say industry analysts.
Texas-based Paragon Healthcare, which serves more than 35,000 patients at more than 40 ambulatory infusion centers across eight states and in their homes, joins BioPlus, the specialty pharmacy subsidiary of CarepathRx which Elevance...
AIS Healthcare receives ACHC accreditation
December 13, 2023HME News Staff
DALLAS – AIS Healthcare, a provider of targeted drug delivery and infusion care solutions has been awarded accreditations for Specialty Pharmacy, Infusion Pharmacy and Infusion Nursing by the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers. This accomplishment underscores the company’s commitment to going beyond what’s expected to advance quality care and improve the lives of patients. “This accomplishment is...
Option Care plans to complete stock repurchase in Q4
December 7, 2023HME News Staff
BANNOCKBURN, Ill. – Option Care Health plans to complete the remaining $75 million of repurchases in the fourth quarter under an original authorization. In addition, the company’s board of directors approved an increase to its share repurchase program authorization from $250 million to $500 million. The program has no specified expiration date. During a call in October to discuss its third quarter earnings, Option Care said it had completed a repurchase of approximately $100 million in...